Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale Chief Technology Officer sold 2,627 shares at $22.77 ($59,817)
  2. 4 Grant or award Chief Financial Officer acquired 66,500 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Regulation FD disclosure
  5. 4 Open-market sale Director sold 17,935 shares at $22.59 ($405,062)
  6. 8-K Event Bylaws or fiscal year change
  7. 4 Open-market sale EVP & Chief Operating Officer sold 1,482 shares at $22.82 ($33,819)
  8. 4 Open-market buy Director bought 2,500 shares at $22.73 ($56,816)
  9. 4 Open-market sale Chief Medical Officer sold 10,320 shares at an average $23.08 ($238,170)
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 10-K Report Annual Report
  12. 4 Open-market sale CFO sold 2,248 shares at $25.97 ($58,387)
  13. 4 Open-market sale Chief Technology Officer sold 2,302 shares at $25.97 ($59,790)
  14. 4 Open-market sale President and CEO sold 27,750 shares at an average $24.53 ($680,747)
  15. 4 Open-market sale Chief Medical Officer sold 2,878 shares at $25.97 ($74,750)
  16. 4 Open-market sale Chief Administrative Officer sold 1,795 shares at $25.97 ($46,622)
  17. 4 Grant or award EVP & Chief Operating Officer acquired 60,000 shares (grant or award)
  18. 4 Open-market sale 10% owner sold 74,477 shares at an average $28.43 ($2,117,336)
  19. 8-K Event Results of operations
  20. 8-K Event Other events

Page 17 of 41 · 806 filings